Champions Oncology (CSBR) Financials

$5.05

$-0.17 (-3.26%)

As on 08-Sep-2026 16:00EDT

Market cap

$73 Mln

Revenue (TTM)

$59 Mln

P/E Ratio

--

P/B Ratio

17.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Operating Revenue	59.43	56.94	50.16	53.87	49.11	41.04
Cost of Revenue	30.90	28.39	29.40	29.53	23.63	21.45
Gross Profit	28.53	28.56	20.75	24.34	25.48	19.59
Operating Expenses	29.67	23.71	27.68	28.79	24.87	19.23
Operating Profit (EBIT)	-1.14	4.85	-6.92	-4.45	0.61	0.37
Other Income	--	--	--	-0.01	-0.02	0.07
Profit before Tax	-0.93	4.63	-7.31	-5.27	0.58	0.44
Provision for Tax	0.25	-0.08	-0.03	0.07	0.04	0.08
Profit after Tax (Net Income)	-1.18	4.70	-7.28	-5.34	0.55	0.36
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-5.34	0.55	0.36

Liabilities ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Shareholder's Funds	3.94	3.77	-1.90	4.64	9.10	7.43
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.00	4.72	6.49	7.94	8.80	8.96
Current Liabilities	19.92	23.85	21.54	21.73	17.48	11.20
Total Liabilities	26.99	32.34	26.13	34.31	35.38	27.59

Assets ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Non-Current Assets	7.77	9.98	12.49	14.85	15.71	14.96
Current Assets	19.22	22.37	13.64	19.46	19.66	12.63
Total Assets	26.99	32.34	26.13	34.31	35.38	27.59
Total Debt*	4.51	6.11	7.43	8.60	9.47	9.60
Net Current Assets	-0.70	-1.48	-7.90	-2.28	2.19	1.43

Cashflow ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Cash From Operating Activities	-4.47	7.39	-6.14	3.96	6.50	-1.68
Cash Flow from Investing Activities	-0.54	-0.39	-0.84	-2.87	-2.38	-3.17
Cash from Financing Activities	0.10	0.17	-0.53	0.01	0.21	1.20
Net Cash Inflow / Outflow	--	--	--	1.11	4.32	-3.66

Financials Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
ROCE (%)	-12.82	61.04	-77.56	-33.56	3.08	2.79
ROE (%)	-30.48	503.05	-532.46	-77.70	6.63	5.78
ROA (%)	-3.96	16.08	-24.08	-15.31	1.74	1.50
EBIT Margin (%)	-1.56	8.12	-14.57	-9.78	1.19	0.89
Net Margin (%)	-1.98	8.26	-14.51	-9.91	1.12	0.88
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Revenue Growth (%)	0.04	0.14	-0.07	0.10	0.20	0.28
EBIT Growth (%)	-120.08	163.30	-38.75	-1,003.43	59.29	123.08
Net Profit Growth (%)	-124.99	164.61	-36.38	-1,073.54	51.38	117.30
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.80	-0.59	-0.88	0.50	0.21	3.17
Close Price ($)	5.96	7.15	4.85	4.92	7.68	10.73
High Price ($)	9.63	11.99	7.32	9.88	11.38	14.68
Low Price ($)	5.50	3.60	4.17	3.75	7.06	7.05
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Debt to Equity	1.15	1.62	-3.90	1.85	1.04	1.29
Short term debt to equity ratio	0.39	0.39	-0.70	0.26	0.12	0.11
Current Ratio	0.96	0.94	0.63	0.90	1.13	1.13
Quick Ratio	--	--	0.63	0.90	--	--
Interest Coverage	--	171.33	-261.00	--	24.29	5.15

Operating Efficiency Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Debtors to sales (%)	22.18	19.73	18.99	14.87	19.37	17.02
Asset Turnover	2.00	1.95	1.66	1.55	1.56	1.70
Receivable days	75.02	66.58	63.86	59.41	61.36	52.31
Inventory Days	--	0.00	0.00	0.00	--	0.00
Payable days	65.90	64.64	69.16	50.72	36.80	42.87
Cash Conversion Cycle	--	1.94	-5.30	8.69	--	9.45